# RISEDRONATE SODIUM
> **ANDA207516** · Abbreviated New Drug Application (Generic) · Sponsor: HANGZHOU BINJIANG · Approved 2019-02-15
## Drug
- **FDA Application Number:** ANDA207516
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** RISEDRONATE SODIUM
- **Generic name:** RISEDRONATE SODIUM
- **Active ingredients:** RISEDRONATE SODIUM
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** HANGZHOU BINJIANG
- **Manufacturer:** Hangzhou Minsheng Binjiang Pharmaceutical CO., Ltd
- **First approval:** 2019-02-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207516)
---
*AI Analytics · CC0 1.0*